2023 / 02

Next Paper
DOI: 10.47183/mes.2023.016

ORIGINAL RESEARCH

Effect of sodium bicarbonate on the development of gastric stasis in the rat model of myeloablative chemotherapy with cyclophosphamide

Vakunenkova OA1, Ivnitsky JuJu1, Gaykova ON1, Kozlov AA1, Schäfer TV2
About authors

1 Golikov Research Clinical Center of Toxicology of the Federal Medical and Biological Agency, Saint-Petersburg, Russia

2 State Scientific Research Test Institute of the Military Medicine of Defense Ministry of the Russian Federation, Saint-Petersburg, Russia

Correspondence should be addressed: Timur V. Schäfer
Lesoparkovaya, 4, Saint-Petersburg, 195043, Russia; ur.xednay@refahcs

About paper

Author contribution: Vakunenkova OA — experimental study; Ivnitsky JuJu — rationale, developing the experimental model, data interpretation and discussion; Gaykova ON — morphometry data interpretation; Kozlov AA — morphometry studies; Schäfer TV — experimental procedure, data processing and visualization, developing the experimental model. All authors contributed to discussion, manuscript writing and editing.

Compliance with ethical standards: the study was carried out in accordance with the principles of bioethics, approved by the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes.

Received: 2023-04-06 Accepted: 2023-05-19 Published online: 2023-06-12
|
  1. Schäfer TV, Ivnitsky JuJu, Rejniuk VL. Modelirovanie mieloablyacionnoj citostaticheskoj terapii soprovozhdaetsya zheludochno-kishechnym stazom u krys. Medicina ehkstremal'nyx situacij. 2022; 1: 51–5. Russian.
  2. Jacobse J, Mensink H, Eileen M, Kollen W, Bresters D, Bredius R. Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic cell transplantation. Bone Marrow Transplantation. 2018; 53 (10): 1372–4.
  3. Shivarudraiah M, Patel A, Singh S. Acute severe gastroparesis (mega-stomach), an unusual complication of autologous stem cell transplantat: a case report. Cancer Research, Statistics, and Treatment. 2022; 5 (3): 584–7.
  4. Patel R, Soni M, Soyantar B, Shivangi S, Sutaria S, Saraf M et al. A clash of quorum sensing vs quorum sensing inhibitors: an overview and risk of resistance. Arch Microbiol. 2023; 205 (4): 107.
  5. Buchholz BM, Bauer AJ. Membrane Tlr signaling mechanisms in the gastrointestinal tract during sepsis. Neurogastroenterology and motility. 2010; 22: 232–45.
  6. Chapman MJ, Nguyen NQ, Deane AM. Gastrointestinal dysmotility: clinical consequences and management of the critically ill patient. Gastroenterol Clin North Am. 2011; 40 (4): 725–39.
  7. Grover M, Gianrico F, Stanghellini V. Gastroparesis: a turning point in understanding and treatment. Gut. 2019; 68 (12): 2238–50.
  8. Zheng T, Camilleri M. Management of gastroparesis. Gastroenterol Hepatol. 2021; 17 (11): 515–25.
  9. Sangild PT, Shen RL, Pontoppidan P, Rathe M. Animal models of chemotherapy-induced mucositis: translational relevance and challenges. Am J Physiol Gastrointest Tract Liver. 2017; 314 (2): G231–G46.
  10. Anderson LW, Chen TL, Colvin OM, Grochow LB, Collins JM, Kennedy MJ, et al. Cyclophosphamide and 4-hydroxycyclophosphamide / aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy. Clin Cancer Res. 1996; 2 (9): 1481–7.
  11. Kuris G, Ambroziak W, Pietruszko R. Human aldehyde dehydrogenase. J Biol Chem. 1989; 264 (8): 4715–21.
  12. Tieze L, Neumann M, Fischer R, Rajewsky M, Jähde E. Protonmediated liberation of aldophosphamide from a nontoxic prodrug: a strategy for tumor-selective activation of cytocidal drug. Cancer Res. 1989; 49 (15): 4179–84.
  13. Schäfer TV, Rejuniuk VL, Malakhovsky VN, Ivnitsky JuJu. Otyagoshhenie ostryx nevrologicheskix rasstrojstv, vyzvannyx ciklofosfanom, pri iskusstvennom snizhenii rN ximusa u krys. Byul. ehksperim. biol. med. 2012; 153 (6): 841–6. Russian.
  14. Rejniuk VL, Schäfer TV, Krasnov KA, Ivnitsky JuJu. Vliyanie ciklofosfana i laktulozy na postuplenie ammiaka i veshhestv srednej molyarnoj massy iz kishechnika v krov' u krys. Byul. ehksperim. biol. med. 2012; 154 (10): 455–9. Russian.
  15. Seydoux C, Medinger M, Gerull S, Halter J, Heim D, Chalandon Y et al. Busulfan-cyclophosphamide versus cyclophosphamidebusulfan as conditioning regimen before allogenic hematopoietic cell transplantation: a prospective randomized trial. Annals of Hematol. 2021; 100 (1): 209–16.
  16. Martynov VL, Semyonov AG, Tulupov AA, Chesnokov AA, Kurilov VA, Kazarina NV. Indikan mochi i vodorodnyj dyxatel'nyj test kak metody skrining-diagnostiki sindroma izbytochnogo bakterial'nogo rosta v tonkoj kishke. Med. al'manax. 2017; 2 (47); 117–21. Russian.
  17. Balakhovskiy SD, Balakhovskiy IS. Metody ximicheskogo analiza krovi. 3-e izd. M.: Medgiz, 1953; 746 s. Russian.
  18. Zar JH. Biostatistical Analysis. 5th ed. Prentice-Hall/Pearson, Upper Saddle River. 2010; 944 p.
  19. O’Grady J, Murphy CL, Burry L, Shanahan F, Buckly M. Defining gastrointestinal transit time using video capsule endoscopy: a study of healthy subjects. Endosc Int Open. 2020; 8 (3): E396– E400.
  20. Yang L, Yan C, Zhang F, Jiang B, Gao S, Liang Y, et al. Effects of ketoconazole on cyclophosphamide metabolism: evaluation of CYP3A4 inhibition effect using the in vitro and in vivo models. Exp Anim. 2018; 67 (1): 71–82.
  21. Sahu K, Langeh U, Singh C, Singh A. Crosstalk between anticancer drugs and mitochondrial functions. Curr Res Pharmacol Drug Discov. 2021; 2: 100047.
  22. Sunil V, Vayas K, Radbel J, Abramova E, Gow A, Laskin J, et al. Impaired energy metabolism and altered functional activity of alveolar type II epithelial cell following exposure of rats to nitrogen mustard. Toxicol Appl Pharmacol. 2022; 456: 116257.
  23. Sender R, Fuchs S. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016; 14 (8): e1002533.
  24. Ijiri K, Potten C. Response of intestinal cells of different topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Brit J Cancer. 1983; 47 (2): 175–85.
  25. Dahlgren D, Sjöblom M, Hellström P, Lennemäs H. Chemotherapeutics-induced intestinal mucositis: pathophysiology and potential treatment strategies. Front Pharmacol. 2021; 12 (Art. 681417): 1–12.